SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $404,000 | +2.3% | 27,000 | -16.8% | 0.02% | -12.0% |
Q1 2016 | $395,000 | -11.2% | 32,461 | +16.1% | 0.02% | +13.6% |
Q4 2015 | $445,000 | -56.4% | 27,960 | -36.3% | 0.02% | -46.3% |
Q1 2015 | $1,021,000 | +228.3% | 43,904 | +265.3% | 0.04% | +192.9% |
Q2 2014 | $311,000 | +15.2% | 12,018 | +13.1% | 0.01% | -33.3% |
Q4 2013 | $270,000 | – | 10,627 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 453,392 | $11,022,000 | 1.89% |
GREAT POINT PARTNERS LLC | 141,900 | $3,450,000 | 1.34% |
Penn Capital Management Company, LLC | 1,247,428 | $30,325,000 | 1.25% |
Ranger Investment Management | 982,240 | $23,878,000 | 1.16% |
HealthCor Management, L.P. | 912,381 | $22,180,000 | 1.12% |
Piermont Capital Management Inc. | 138,380 | $3,364,000 | 1.02% |
JW Asset Management, LLC | 111,630 | $2,714,000 | 0.82% |
SECTORAL ASSET MANAGEMENT INC | 465,625 | $11,319,000 | 0.47% |
ACUTA CAPITAL PARTNERS, LLC | 28,000 | $681,000 | 0.42% |
Tekla Capital Management LLC | 409,500 | $9,955,000 | 0.36% |